コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 1 (ACK1; also known as Tnk2, tyrosine kinase non-receptor 2) as a novel binding partner of SLP-76.
2 monstrated that protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associat
3 we report that protein tyrosine phosphatase non-receptor 3 (PTPN3) profoundly potentiates TGF-beta s
4 ow that inositol hexakisphosphate (IP6) is a non-receptor activator of arrestin-3 and report the stru
10 nce that G proteins can also be activated by non-receptor binding partners, and they can signal from
11 IgE-Fc mutant that is trapped in the closed, non-receptor binding state via an engineered disulfide a
13 , an octamer capped peptide derived from the non-receptor-binding region of urokinase plasminogen act
18 in-tyrosine phosphatases (RPTPs), like their non-receptor counterparts, regulate the level of phospho
22 anism of G-protein activation by a family of non-receptor GEFs containing a Galpha-binding and -activ
23 ing vesicle-associated protein) is the first non-receptor guanine nucleotide exchange factor (GEF) th
26 We have previously demonstrated that the non-receptor guanine nucleotide exchange factor RIC8 act
27 More specifically, we found that GIV is a non-receptor guanine nucleotide exchange factor that act
28 s on members of a newly identified family of non-receptor guanine nucleotide exchange factors (GEFs),
29 i is activated in the Golgi by GIV/Girdin, a non-receptor guanine-nucleotide exchange factor (GEF).
30 out by G-protein-coupled receptors (GPCRs), non-receptor guanine-nucleotide exchange factors (GEFs)
34 rectly stimulates the activity of a purified non-receptor kinase, Bruton's tyrosine kinase (Btk), whe
41 vation of feedback mechanisms resulting from non-receptor mediated displacement of intraneuronal dopa
47 endovesiculation can be achieved by simple (non-receptor-mediated) mechanical perturbation of the er
48 ors coupled to membrane receptors or through non-receptor pathways by stimuli such as heat shock, UV
52 (interleukin-2 inducible T cell kinase) is a non-receptor protein tyrosine kinase expressed primarily
58 ton's tyrosine kinase (Btk), a hematopoietic non-receptor protein tyrosine kinase that is critical fo
61 CR cross-linking activates three families of non-receptor protein tyrosine kinases (PTKs) and these a
62 addition, the activity of both receptor and non-receptor protein tyrosine kinases along with numerou
64 dermal growth factor receptor (EGFR) and the non-receptor protein tyrosine kinases Src and Pyk2 have
65 ll antigen receptor (TCR) activates a set of non-receptor protein tyrosine kinases that assist in del
66 otein Dab1, Src and Fyn of the Src-family of non-receptor protein tyrosine kinases, and CrkL) are loc
68 osine phosphatase (HePTP) is a 38kDa class I non-receptor protein tyrosine phosphatase (PTP) that is
69 in physically associates with and degrades a non-receptor protein tyrosine phosphatase (PTPN13), and
71 of Corkscrew, the drosophila ortholog of the non-receptor protein tyrosine phosphatase type II (SHP2)
75 rtners and suggest a general role for BCR in non-receptor protein-tyrosine kinase regulation and sign
77 gene encoding a member of the Csk family of non-receptor protein-tyrosine kinases (PTKs) in the earl
78 monstrate here that US28 signals through the non-receptor protein-tyrosine kinases Src and focal adhe
79 sion kinase (FAK) is a member of a family of non-receptor protein-tyrosine kinases that regulates int
82 decrease in the activity of the receptor and non-receptor protein-tyrosine phosphatases that down-reg
84 ted Akt stimulation is regulated by multiple non-receptor PTK families which regulate Akt both proxim
85 ns, whose boundaries are distinct from other non-receptor PTK family members, again indicating a stru
88 le proteins, while the fusion of receptor or non-receptor sequences upstream of 537-673 afforded stab
89 s that a WW domain-mediated process, such as non-receptor signaling, protein degradation or pre-mRNA
90 , we employed pharmacological inhibitors for non-receptor Src homology-2 domain-containing protein ty
97 s in the protein tyrosine phosphatase (PTP), non-receptor type 11 (PTPN11) gene that encodes the SH2
98 per was from a protein tyrosine phosphatase, non-receptor type 11 (Ptpn11) mutated allele encoding Sh
99 : a pathogenic protein tyrosine phosphatase, non-receptor type 11 (PTPN11) variant and variants of un
100 e reported that tyrosine-protein phosphatase non-receptor type 11 (SHP-2) and phosphatidylinositol 3-
102 n expression of tyrosine-protein phosphatase non-receptor type 13 or FAS associated phosphatase 1 (FA
103 ing of PTPN14 (protein tyrosine phosphatase, non-receptor type 14) which, in turn, regulated the Hipp
104 locus encoding protein-tyrosine phosphatase non-receptor type 2 (PTPN2) has been associated with inf
106 nase FYN (FYN), protein tyrosine phosphatase non-receptor type 2 (PTPN2), and adenylate cyclase-assoc
107 stablished that protein tyrosine phosphatase non-receptor type 22 (PTPN22) is a key regulator of T ce
108 A variant in protein tyrosine phosphatase non-receptor type 22 (PTPN22) is associated with reduced
113 entified in the protein tyrosine phosphatase non-receptor type 6 (PTPN6) gene, also known as SHP-1, a
117 e c-Yes proto-oncogene (pp62c-Yes) encodes a non-receptor-type protein tyrosine kinase (NRPTK) of the
118 t mutations in PTPN11, the gene encoding the non-receptor-type protein tyrosine phosphatase SHP-2 (sr
119 brary screening and identified Fer kinase, a non-receptor-type tyrosine kinase, as a key regulator of
120 ed receptor may initiate the cross-talk with non-receptor-type tyrosine kinases, thereby activating p
121 ion, among those the catalytically inactive, non-receptor-type tyrosine phosphatase PTPN23/HD-PTP.
127 orylated in vitro by representatives of many non-receptor tyrosine kinase (NRTK) sub-families, sugges
131 We have previously shown that the Arg/Abl2 non-receptor tyrosine kinase acts downstream of the EGF
132 nism by which an adaptor protein activates a non-receptor tyrosine kinase by SH2 domain displacement.
136 ronal morphogenesis, we demonstrate that the non-receptor tyrosine kinase c-Abl is an intermediary fo
137 Here, we show that the stress-signaling non-receptor tyrosine kinase c-Abl links parkin to spora
141 pe-selective small molecule inhibitor of the non-receptor tyrosine kinase c-Src (IC(50) = 64 nM).
142 determined that tTG forms a complex with the non-receptor tyrosine kinase c-Src and PI3-kinase, and t
143 e G proteins through a pathway involving the non-receptor tyrosine kinase c-Src and the G protein Ras
144 macrophage colony-stimulating factor and the non-receptor tyrosine kinase c-Src play critical roles i
145 ubiquitination of another protooncogene, the non-receptor tyrosine kinase c-Src, as well as of itself
147 Herein we demonstrate that activity of the non-receptor tyrosine kinase dBtk protein is required wi
149 reviously showed that targeted expression of non-receptor tyrosine kinase Etk/BMX in mouse prostate i
153 tyrosine kinase (BTK) is a member of the Tec non-receptor tyrosine kinase family that is involved in
155 nase-1 (FRK-1), an ortholog of the mammalian non-receptor tyrosine kinase Fer, is necessary for embry
158 long cytoskeletal filaments and activate the non-receptor tyrosine kinase focal adhesion kinase, whic
159 ignaling protein, the ubiquitously expressed non-receptor tyrosine kinase focal adhesion kinase.
160 Herein, we identified a novel role for the non-receptor tyrosine kinase Fyn in regulating neuroinfl
161 ngest interaction was between MAP-2c and the non-receptor tyrosine kinase Fyn; however, MAP-2b and MA
163 h tyrosine kinase 2 (PYK2) is a cytoplasmic, non-receptor tyrosine kinase implicated in multiple sign
166 en hMSH5 and c-Abl; the latter is a critical non-receptor tyrosine kinase involved in many critical c
169 ed receptors, results in the activation of a non-receptor tyrosine kinase known as focal adhesion kin
171 blished that BCR is a substrate for c-FES, a non-receptor tyrosine kinase linked to myeloid growth an
173 ase (FAK) potently, we explored whether this non-receptor tyrosine kinase participates in the activat
176 n that binds to and is phosphorylated by the non-receptor tyrosine kinase PYK2, contains several modu
182 d pharmacologic approaches identify that the non-receptor tyrosine kinase Src is required for FN tran
183 ownstream signalling mechanisms, such as the non-receptor tyrosine kinase Src or N-methyl-D-aspartate
186 in (LRP) was found to be a substrate for the non-receptor tyrosine kinase Src, but the physiological
187 -Cbl also acts as a ubiquitin ligase for the non-receptor tyrosine kinase Src, thereby down-regulatin
189 ted that integrin-mediated activation of the non-receptor tyrosine kinase Syk in hematopoietic cells
190 vated Cdc42-associated kinase-2 (ACK-2) is a non-receptor tyrosine kinase that appears to be a highly
200 uton's tyrosine kinase (Btk) is a Tec family non-receptor tyrosine kinase that plays a critical role
201 target of the enzymatic activity of c-Abl, a non-receptor tyrosine kinase that potently activated in
203 ivated Cdc42-associated kinase-2 (ACK2) is a non-receptor tyrosine kinase that serves as a specific e
206 , encoded by the TNK2 gene, is a cytoplasmic non-receptor tyrosine kinase whose aberrant activation c
209 canonical signaling mechanisms such as Src (non-receptor tyrosine kinase), PI3K, ERK, or MAPK pathwa
213 tudy, we have identified SAM domain-carrying non-receptor tyrosine kinase, activated Cdc42-associated
214 ts with the SH3 domain of Fyn, an Src family non-receptor tyrosine kinase, and is tyrosine-phosphoryl
215 nsistent with genetic studies placing Abl, a non-receptor tyrosine kinase, and the Drosophila ortholo
216 t of the vesicular regulator, dynamin 2, the non-receptor tyrosine kinase, c-Abl, and the NADPH oxida
217 resent study, we examined the role of Fyn, a non-receptor tyrosine kinase, in microglial activation a
218 or TNK2, an ubiquitously expressed oncogenic non-receptor tyrosine kinase, integrates signals from li
223 motes signaling by causing activation of the non-receptor tyrosine kinase, JAK2, which associates wit
225 e reported previously that Janus kinase 3, a non-receptor tyrosine kinase, plays a crucial role in AJ
226 increase in tyrosine phosphorylation of the non-receptor tyrosine kinase, PYK2, in A7r5 cells treate
228 h collagen induced a rapid activation of the non-receptor tyrosine kinase, Syk, as measured by an inc
230 he identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been impli
238 belson family kinases (AFKs; Abl1, Abl2) are non-receptor tyrosine kinases (NRTKs) implicated in canc
240 eelin activates members of the Src family of non-receptor tyrosine kinases (SFKs) and that this activ
241 ein kinase IIdelta2 (CaMKIIdelta2) activates non-receptor tyrosine kinases and EGF receptor, with a S
242 receptor tyrosine kinases, the Src family of non-receptor tyrosine kinases and the Eph receptor tyros
243 members of the Janus kinase (Jak) family of non-receptor tyrosine kinases and the signal transducers
244 d p160(v-Abl) are plasma membrane-associated non-receptor tyrosine kinases and the transforming activ
248 substrate of all the three major classes of non-receptor tyrosine kinases associated with the IL-2R,
249 ough members from three distinct families of non-receptor tyrosine kinases can phosphorylate PLCgamma
252 eptor tyrosine kinases and the Abl family of non-receptor tyrosine kinases have both been implicated
253 inases (SrcFKs), a multi-functional group of non-receptor tyrosine kinases highly expressed in vascul
254 , PF-4618433) reveals a distinct subclass of non-receptor tyrosine kinases identifiable by the gateke
255 lopment and represents an emerging family of non-receptor tyrosine kinases implicated in signal trans
257 stimulation of VGSC, engagement of these two non-receptor tyrosine kinases involves distinct signalin
258 to-oncogenes encode 60 000 and 62 000 Dalton non-receptor tyrosine kinases of the Src family, pp60c-s
259 orylation of cellular proteins including the non-receptor tyrosine kinases p125fak and Src and the ad
262 nsights into the mechanisms by which Abelson non-receptor tyrosine kinases relay information from axo
263 relationship between Notch and either of the non-receptor tyrosine kinases Src42A and Src64B to promo
266 kinase (FAK) and its close relative Pyk2 are non-receptor tyrosine kinases that mediate adhesion sign
267 d gene) protein belongs to the Abl family of non-receptor tyrosine kinases that regulate cell motilit
268 s a novel negative regulator of receptor and non-receptor tyrosine kinases through currently undefine
269 eration, we asked whether the recruitment of non-receptor tyrosine kinases to the cytoskeleton might
271 protein Hck is a member of the Src family of non-receptor tyrosine kinases which is preferentially ex
272 kinase Itk is a member of the Tec family of non-receptor tyrosine kinases, and is required for signa
273 ted conformations that provide access to the non-receptor tyrosine kinases, BCR-ABL and Src, which ph
275 Thus, these studies strongly suggest that non-receptor tyrosine kinases, in particular c-Src, may
277 e of signaling nodes Itk and Txk, Tec family non-receptor tyrosine kinases, mice exhibit a significan
279 Btk family kinases represent new members of non-receptor tyrosine kinases, which include Btk/Atk, It
280 main containing proteins, including specific non-receptor tyrosine kinases-Abl via pY251 and C-termin
289 cogenic function via direct interaction with non-receptor tyrosine phosphatase 14 (PTPN14) through th
291 RNA interference (RNAi) screening identified non-receptor tyrosine phosphatases (PTPNs) required for
292 osine kinases (protein-tyrosine kinases) and non-receptor tyrosine phosphatases (PTPs) have been impl
295 In this work we describe the profiling of a non-receptor tyrosine-protein kinase (TYK2) inhibitor wh
299 osine phosphorylation of GIV by receptor and non-receptor-tyrosine kinases is a key step that is requ
300 SHP-1 antagonizes the action of receptor and non-receptor-tyrosine kinases on GIV and down-regulates